{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:14:03Z","timestamp":1790007243273,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.leukres.2008.05.015","type":"journal-article","created":{"date-parts":[[2008,7,10]],"date-time":"2008-07-10T05:52:31Z","timestamp":1215669151000},"page":"1842-1848","source":"Crossref","is-referenced-by-count":13,"title":["A Pilot study of allogeneic cellular therapy for patients with advanced hematologic malignancies"],"prefix":"10.1016","volume":"32","author":[{"given":"Daniel J.","family":"Medina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mecide","family":"Gharibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Cohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy","family":"Kuriyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binaifer","family":"Balsara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Schaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Krimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Saggiomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Manago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Talty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesel","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Grospe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger K.","family":"Strair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.leukres.2008.05.015_bib1","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1200\/JCO.2005.00.240","article-title":"Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma","volume":"23","author":"Dudley","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.leukres.2008.05.015_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2370.2003.00384.x","article-title":"Tumour immunology, vaccination and escape strategies","volume":"30","author":"Garcia-Lora","year":"2003","journal-title":"Eur J Immunogenet"},{"issue":"1","key":"10.1016\/j.leukres.2008.05.015_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00262-005-0706-1","article-title":"Adoptive T cell therapy of solid cancers","volume":"55","author":"Knutson","year":"2006","journal-title":"Cancer Immunol Immunother"},{"issue":"12","key":"10.1016\/j.leukres.2008.05.015_bib4","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ncponc0666","article-title":"Increased intensity lymphodepletion and adoptive immunotherapy\u2014how far can we go?","volume":"3","author":"Muranski","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"issue":"6835","key":"10.1016\/j.leukres.2008.05.015_bib5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/35077246","article-title":"Progress in human tumour immunology and immunotherapy","volume":"411","author":"Rosenberg","year":"2001","journal-title":"Nature"},{"issue":"Suppl 2","key":"10.1016\/j.leukres.2008.05.015_bib6","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.1073\/pnas.0405730101","article-title":"Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes","volume":"101","author":"Rosenberg","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.leukres.2008.05.015_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.leukres.2008.05.015_bib8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1189\/jlb.1105628","article-title":"Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response","volume":"79","author":"Frey","year":"2006","journal-title":"J Leukoc Biol"},{"issue":"4","key":"10.1016\/j.leukres.2008.05.015_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.leukres.2008.05.015_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1074-7613(03)00359-5","article-title":"Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy","volume":"20","author":"Wang","year":"2004","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.leukres.2008.05.015_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00262-003-0444-1","article-title":"Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells","volume":"53","author":"Wei","year":"2004","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"10.1016\/j.leukres.2008.05.015_bib12","first-page":"606","article-title":"Increase of regulatory T cells in the peripheral blood of cancer patients","volume":"9","author":"Wolf","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.leukres.2008.05.015_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood.V100.2.442","article-title":"Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy","volume":"100","author":"Ballen","year":"2002","journal-title":"Blood"},{"issue":"1\u20133","key":"10.1016\/j.leukres.2008.05.015_bib14","first-page":"191","article-title":"Nonmyeloablative blood stem cell transplantation as adoptive allogeneic immunotherapy for metastatic renal cell carcinoma","volume":"21","author":"Childs","year":"2001","journal-title":"Crit Rev Immunol"},{"issue":"9","key":"10.1016\/j.leukres.2008.05.015_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0301-472X(03)00190-5","article-title":"Minor histocompatibility antigens in human stem cell transplantation","volume":"31","author":"Falkenburg","year":"2003","journal-title":"Exp Hematol"},{"issue":"3","key":"10.1016\/j.leukres.2008.05.015_bib16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.beha.2004.05.008","article-title":"Minor histocompatibility antigens as targets of cellular immunotherapy in leukaemia","volume":"17","author":"Falkenburg","year":"2004","journal-title":"Best Pract Res Clin Haematol"},{"issue":"3","key":"10.1016\/j.leukres.2008.05.015_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0268-960X(03)00007-9","article-title":"The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Riddell","year":"2003","journal-title":"Blood Rev"},{"issue":"3","key":"10.1016\/j.leukres.2008.05.015_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF02983795","article-title":"Graft-versus-host disease, the graft-versus-leukemia effect, and mixed chimerism following nonmyeloablative stem cell transplantation","volume":"78","author":"Slavin","year":"2003","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1016\/j.leukres.2008.05.015_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/152581602753658457","article-title":"Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation","volume":"11","author":"Slavin","year":"2002","journal-title":"J Hematother Stem Cell Res"},{"issue":"12","key":"10.1016\/j.leukres.2008.05.015_bib20","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1172\/JCI27094","article-title":"Expanding the immunotherapeutic potential of minor histocompatibility antigens","volume":"115","author":"Spierings","year":"2005","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.leukres.2008.05.015_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00130404-200401000-00001","article-title":"Minor histocompatibility antigens: allo target molecules for tumor-specific immunotherapy","volume":"10","author":"Goulmy","year":"2004","journal-title":"Cancer J"},{"issue":"4","key":"10.1016\/j.leukres.2008.05.015_bib22","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.beha.2006.06.004","article-title":"Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation","volume":"19","author":"Passweg","year":"2006","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.leukres.2008.05.015_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1600-065X.2006.00455.x","article-title":"Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self","volume":"214","author":"Ruggeri","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.leukres.2008.05.015_bib24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1182\/asheducation-2005.1.390","article-title":"Haploidentical stem cell transplantation: the always present but overlooked donor","author":"Spitzer","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"12","key":"10.1016\/j.leukres.2008.05.015_bib25","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.exphem.2005.06.032","article-title":"Cellular immune therapy for refractory cancers: novel therapeutic strategies","volume":"33","author":"Ballen","year":"2005","journal-title":"Exp Hematol"},{"issue":"5","key":"10.1016\/j.leukres.2008.05.015_bib26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/10428190310001628167","article-title":"Low dose total body irradiation followed by allogeneic lymphocyte infusion for refractory hematologic malignancy\u2014an updated review","volume":"45","author":"Ballen","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.leukres.2008.05.015_bib27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2141.2004.05328.x","article-title":"Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation","volume":"128","author":"Dey","year":"2005","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.leukres.2008.05.015_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2141.2006.06300.x","article-title":"Current status of haploidentical stem cell transplantation","volume":"135","author":"Dey","year":"2006","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.leukres.2008.05.015_bib29","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.1999.17.4.1234","article-title":"Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies","volume":"17","author":"Porter","year":"1999","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.leukres.2008.05.015_bib30","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood-2002-12-3949","article-title":"Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-gamma","volume":"102","author":"Rubio","year":"2003","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.leukres.2008.05.015_bib31","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1200\/JCO.2003.05.094","article-title":"Antineoplastic effects of partially HLA-matched irradiated blood mononuclear cells in patients with renal cell carcinoma","volume":"21","author":"Strair","year":"2003","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.leukres.2008.05.015_bib32","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.leukres.2008.05.015_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0065-230X(06)95008-8","article-title":"Innate immune recognition and suppression of tumors","volume":"95","author":"Hayakawa","year":"2006","journal-title":"Adv Cancer Res"},{"issue":"6","key":"10.1016\/j.leukres.2008.05.015_bib34","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1200\/JCO.2004.10.041","article-title":"Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance","volume":"22","author":"Mapara","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.leukres.2008.05.015_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/gb-2005-6-3-211","article-title":"Tumor microenvironments, the immune system and cancer survival","volume":"6","author":"Strausberg","year":"2005","journal-title":"Genome Biol"},{"issue":"2","key":"10.1016\/j.leukres.2008.05.015_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcancer.2005.11.005","article-title":"T cells in immune surveillance and treatment of cancer","volume":"16","author":"Yamaguchi","year":"2006","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"10.1016\/j.leukres.2008.05.015_bib37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri1936","article-title":"Cancer despite immunosurveillance: immunoselection and immunosubversion","volume":"6","author":"Zitvogel","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.leukres.2008.05.015_bib38","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/sj.bjc.6600223","article-title":"Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes","volume":"86","author":"Savage","year":"2002","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.leukres.2008.05.015_bib39","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1182\/blood-2003-11-3903","article-title":"Use of B cell-bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen","volume":"103","author":"Savage","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2008.05.015_bib40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000099152","article-title":"Expansion of CD8+ cytotoxic T cells in vitro and in vivo using MHC class I tetramers","volume":"28","author":"Savage","year":"2007","journal-title":"Tumour Biol"},{"issue":"1\u20132","key":"10.1016\/j.leukres.2008.05.015_bib41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-1759(01)00359-3","article-title":"A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity","volume":"253","author":"Lecoeur","year":"2001","journal-title":"J Immunol Methods"},{"issue":"56","key":"10.1016\/j.leukres.2008.05.015_bib42","doi-asserted-by":"crossref","first-page":"8668","DOI":"10.1038\/sj.onc.1206093","article-title":"The basis of T-cell-mediated immunity to chronic myelogenous leukemia","volume":"21","author":"Molldrem","year":"2002","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.leukres.2008.05.015_bib43","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1172\/JCI200316398","article-title":"Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells","volume":"111","author":"Molldrem","year":"2003","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.leukres.2008.05.015_bib44","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/79526","article-title":"Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia","volume":"6","author":"Molldrem","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2008.05.015_bib45","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/asheducation-2003.1.350","article-title":"New developments in allotransplant immunology","author":"Barrett","year":"2003","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"10","key":"10.1016\/j.leukres.2008.05.015_bib46","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2003-03-0861","article-title":"Clonal dominance of chronic myelogenous leukemia is associated with diminished sensitivity to the antiproliferative effects of neutrophil elastase","volume":"102","author":"El-Ouriaghli","year":"2003","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2008.05.015_bib47","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1182\/blood-2003-01-0150","article-title":"Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation","volume":"102","author":"Rezvani","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2008.05.015_bib48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/14653240701218524","article-title":"Transfer of PR1-specific T-cell clones from donor to recipient by stem cell transplantation and association with GvL activity","volume":"9","author":"Rezvani","year":"2007","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.leukres.2008.05.015_bib49","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2007-08-108241","article-title":"Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies","volume":"111","author":"Rezvani","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2008.05.015_bib50","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood-2007-02-071738","article-title":"High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects","volume":"110","author":"Yong","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2008.05.015_bib51","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1470-2045(04)01649-3","article-title":"Part II. Vaccines for haematological malignant disorders","volume":"5","author":"Mocellin","year":"2004","journal-title":"Lancet Oncol"},{"issue":"1 Suppl 1","key":"10.1016\/j.leukres.2008.05.015_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbmt.2005.10.014","article-title":"Vaccination for leukemia","volume":"12","author":"Molldrem","year":"2006","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608002518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608002518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T11:54:05Z","timestamp":1557662045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212608002518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0145212608002518"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2008.05.015","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}